Stockreport

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering [Yahoo! Finance]

ProKidney Corp. - Class A Ordinary Shares  (PROK) 
PDF cellular therapeutics company focused on chronic kidney disease, today announced that it has commenced an underwritten public offering and a concurrent registered direct [Read more]